000 | 01947 a2200553 4500 | ||
---|---|---|---|
005 | 20250516212056.0 | ||
264 | 0 | _c20140902 | |
008 | 201409s 0 0 eng d | ||
022 | _a1528-0020 | ||
024 | 7 |
_a10.1182/blood-2014-01-549360 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGómez-Almaguer, David | |
245 | 0 | 0 |
_aEltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults. _h[electronic resource] |
260 |
_bBlood _cJun 2014 |
||
300 |
_a3906-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
650 | 0 | 4 |
_aBenzoates _xadministration & dosage |
650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrazines _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPlatelet Count |
650 | 0 | 4 |
_aPurpura, Thrombocytopenic, Idiopathic _xdrug therapy |
650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
650 | 0 | 4 |
_aReceptors, Thrombopoietin _xagonists |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHerrera-Rojas, Miguel A | |
700 | 1 | _aJaime-Pérez, José C | |
700 | 1 | _aGómez-De León, Andrés | |
700 | 1 | _aCantú-Rodríguez, Olga G | |
700 | 1 | _aGutiérrez-Aguirre, César H | |
700 | 1 | _aTarín-Arzaga, Luz | |
700 | 1 | _aHernández-Reyes, Jesús | |
700 | 1 | _aRuiz-Arguelles, Guillermo J | |
773 | 0 |
_tBlood _gvol. 123 _gno. 25 _gp. 3906-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2014-01-549360 _zAvailable from publisher's website |
999 |
_c23801947 _d23801947 |